Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
HURA
HURA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HURA News
TuHURA Biosciences Regains Nasdaq Compliance
Feb 27 2026
PRnewswire
TuHURA Biosciences Regains Nasdaq Compliance
Feb 27 2026
Newsfilter
TuHURA Biosciences to Participate in Upcoming Investor Conferences
Feb 24 2026
PRnewswire
TuHURA Biosciences to Participate in Upcoming Investor Conferences
Feb 24 2026
Newsfilter
TuHURA Files IND for TBS-2025 in AML Treatment
Feb 17 2026
PRnewswire
TuHURA Biosciences to Present at Oppenheimer Healthcare Conference
Feb 12 2026
PRnewswire
TuHURA Biosciences Receives Orphan Drug Designation for IFx-2.0
Feb 03 2026
stocktwits
TuHURA Biosciences Receives FDA Orphan Drug Designation
Feb 02 2026
Newsfilter
TuHURA Receives FDA Orphan Drug Designation
Feb 02 2026
PRnewswire
TuHURA Biosciences Releases 1.54M Shares to Kintara CVR Holders Following Clinical Trial Success
Dec 15 2025
PRnewswire
TuHURA Biosciences Advances Phase 3 Trial of IFx-2.0 for Merkel Cell Carcinoma
Dec 11 2025
PRnewswire
Post-Market Surge: Stoke Therapeutics, Alpha Tau Medical, and Compass Pathways Top Biotech Gainers
Dec 10 2025
NASDAQ.COM
TuHURA Biosciences Announces $1.65 Share Offering of 9.46 Million Shares
Dec 09 2025
PRnewswire
TuHURA Biosciences Issues 9.46M Shares at $1.65 Each in Direct Offering
Dec 09 2025
Newsfilter
Maxim Group Continues to Recommend Buy for TuHURA Biosciences (HURA)
Nov 15 2025
NASDAQ.COM
TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Nov 14 2025
PRnewswire
Show More News
